Human antibody neutralizing lymphocytic cboriomeningitis virus is most reliably determined in mice as assay hosts. Whereas the previously recommended procedure yielding a neutralization index requires much serum, the method described here uses only o. I ml. An equal mixture of virus and serum is incubated and residual infectivity is titrated intracerebrally in mice. The neutralizing activity is given by the ratio of virus surviving after incubation with control serum and with the test serum respectively. This ratio is called the neutralization factor.
INTRODUCTION
There are few satisfactory methods available at present for detecting lymphocytic choriomeningitis (LCM) virus-specific antibcdies in human sera. The widely employed complement fixation test often leads to false negative results, even when the antigen is of high potency (reviewed in Lehmann-Grube, i97 I, and unpublished observations). The microplaque reduction assay does not detect all human infections either (Hotchin & Kinch, I975) . Other procedures, purported to be more reliable (Blechschmidt et al. I977; Thacker et al. r977) , require special facilities. I know of only two established methods which give consistent results; recent infections may be detected by the indirect immunofluorescence procedure (Cohen et al. I966; Lewis et al. I975) and past infections are best diagnosed by determining the neutralization index in mice (Lehmann-Grube et al. I96O; Scheid et al. 196o) .
While human LCM virus infections were considered rare events by most physicians, there was no urgency to improve available methods. However, when it became known that the golden hamster (Mesocricetus auratus), a favourite family pet, may transmit LCM virus to humans (Ackermann et al. I97z; Gregg, I975) and that the virus may cause malformations of the foetus if pregnant women are infected (Ackermann et al. I974; Sheinbergas, ~975; Sheinbergas, I976) , the attitude changed and today this agent is considered a relevant human pathogen. As a consequence, virus laboratories including our own were confronted with many requests to confirm or disprove LCM virus infections.
Often the LCM disease was suspected to have occurred many years ago and in such cases we initially determined the neutralization index. This method gives reliable results, but it employs animals and requires at least I.Z5 ml of serum. Development of a plaque reduction assay for measuring virus-sensitizing antibody (kehmann-Grube & Ambrassat, I977) has overcome both these disadvantages. However, not all diagnostic laboratories have the required cell cultures at their disposal and, in addition, a laboratory report based on virus-sensitizing rather than the more familiar neutralizing antibody is sometimes viewed with suspicion by the receiving physician. Since this tends to maintain the demand for neutralization tests, it was decided to undertake a modification of the mouse assay so as to reduce the quantity of serum needed. The method to be described allows titration of LCM virus-neutralizing human antibody on as little as o-I mI of serum. It is easy to perform and appears to be reliable.
In order to avoid confusion with other measures of antibody concentration, such as neutralization index and neutralizing titre, it is proposed that the resulting numerical value be termed the neutralization factor (NF).
METHODS
NMRI mice, 4 to 6 weeks old, were purchased from the Zentralinstitut fiir Versuchstiere, Hannover, Federal Republic of Germany. LCM virus strain WE (Rivers & Scott, I936) was used throughout. Diluent for all purposes was a tris-buffered balanced salt solution (TBS) (Lehmann-Grube & Ambrassat, 1977) supplemented with 1% heated calf serum and penicillin and streptomycin at concentrations of 5oo units and 5oo #g/ml, respectively.
For the production of stock virus newborn mice were infected intracerebrally when less than 2 days old and their brains were homogenized 6 days later as a Io% suspension in diluent. The homogenate was centrifuged for IO min in the cold at approx. 25oo g and the supernatant was ampouled, snapfrozen in a COs-alcohol bath and stored at -7 ° °C. Virus was also propagated in primary monkey kidney (MoK) cells and in permanent BHK21 and L cell lines which were cultivated according to published procedures (LehmannGrube, I965). Maintenance medium after infection consisted of Eagle's minimum essential medium supplemented with non-essential amino acids (Lockart & Eagle, I959) , 1% heated horse serum for MoK cells and Io % heated calf serum for BHK2I and L cells, and penicillin and streptomycin at concentrations of IOO units and IOO #g/ml, respectively. Cell-associated and released virus was harvested 2 days after infection of the cultures and was processed and stored essentially as described for the brain homogenate.
For titration, virus was diluted serially ten-fold and each mouse in groups of five per dilution step received o'o3 ml by intracerebral inoculation. Calculation of the LDs0 according to Fazekas de St. Groth (r955) was based on mice dying between day 5 and I4 after infection. Due to the great lability of this virus (Lehmann-Grube, i968), all manipulations were performed at ~< 4 °C unless stated otherwise.
Human immune sera were taken from known cases of past LCM virus infections, either through occupational contact with the virus or as a result of natural exposure. In some donors the disease had been diagnosed clinically and confirmed by isolation of the virus and/or appearance of antibodies, but in the majority previous infection was demonstrated by a significant neutralization index as well as high titres of sensitizing antibody. Control sera were taken from persons not known to have had lymphocytic choriomeningitis and known to be free of LCM virus-specific antibodies as shown by at least two independent procedures, always including determination of the neutralization index and a search for sensitizing antibody.
Sera were stored in portions at -20 °C; they were used native or heated for 30 min at 56 °C (inactivated).
RESULTS
After some preliminary experiments, titration of LCM virus-neutralizing antibody in human sera was carried out as follows. LCM virus, prepared from brains of infected newborn mice, was diluted to contain lO 5 LDs0/o.o3 ml. To o'25 ml of the virus dilution 0"25 ml of undiluted human serum was added and this reaction mixture was incubated for 2 h at 37 °C in a water bath. It was then transferred to an ice bath to be titrated in mice as described above. The neutralization factor (NF) of a serum is defined as the ratio of titres obtained with virus incubated in the presence of heat-inactivated control serum and virus incubated in the presence of the test serum. In this paper, the NF is always expressed in log10 values, and log10 values were used to calculate means and standard deviations.
Effect of host used for propagating the assay virus on the neutralization test
As is known from earlier work Scheid et aI. 196o; Ackermann et al. I962) , most human sera contain heat-labile inhibitors of virus infectivity. Anticipating that sera would have to be employed in their native state, the possibility was explored that inhibition would be less if the assay virus were propagated in other hosts. In addition to mouse brain virus, virus pools were prepared in MoK, BHK2I and L cells, and the effects of native and inactivated non-immune human sera on these viruses were determined in parallel. In four experiments a total of ten sera were tested. Taking the titres with inactivated sera as the baseline, inhibitors were even more active against virus prepared in L cells (log10 mean and single standard deviation of differences of virus titres obtained after incubation with either native or inactivated sera: I'913 + 0"472) or in MoK cells (v4oo+ 0.260) than against virus prepared in brains of mice (o.362_+ o'355). The inhibition of BHKz i-propagated virus by these ten sera was comparable with that of the mouse brain virus (o.427_+ o'31I).
In a further experiment the effects of three immune sera against these four virus preparations were determined in parallel (data not shown). Differences between native and inactivated sera followed the same pattern but were even more marked. The results also indicated that inactivation reduced the neutralizing capacity of human immune sera.
On the basis of these findings, mouse brain-propagated virus was employed in all subsequent experiments.
Effect of the dose of virus on the neutralization test
Mouse brain-propagated virus was diluted in 3.I6-fold (logx0 o'5) steps and to o'25 ml samples an equal volume of undiluted immune serum, heat-inactivated or native, was added. The naixtures were incubated 2 h at 37 °C and were then titrated in mice. To allow calculation of the amount of infectious virus actually present, virus plus heat-inactivated nonimmune serum was incubated in parallel and ten rather than the usual five mice were employed per dilution step.
The results of one such experiment are presented in Table I . The NF varies about the mean value, but there is no discernible trend, i.e. the NF values are independent of the dose of virus present in the reaction mixture. Heating the serum again considerably reduced its neutralizing titre. This experiment was repeated twice with immune sera from other donors, with essentially the same results.
The effect of heat inactivation of immune sera on neutralization factors
In order to define in quantitative terms the loss of neutralizing capacity on heating, samples of 13 sera from as many immune donors were inactivated for 3o rain at 56 °C. F. LEHMANN-GRUBE In parallel with native seca from the same donors, they were added to equal volumes of mouse brain-propagated virus containing lO 5 LDs~/o'o3 ml. After incubation at 37 °C the mixtures were titrated in mice. The mean and the single standard deviation of the reduction of the neutralization factors after heat inactivation of the sera amounted to o'613 +o'67o (N = I3).
On the basis of these results, non-inactivated sera were used in all subsequent experiments.
Determination of the optimal incubation time
Up to now, the reaction mixtures have been incubated for 2 h, which is a long period for an agent as labile as the LCM virus. Not surprisingly, control titrations performed before and after incubation revealed that infectivity had often dropped two-or even threefold. It was therefore of interest to determine whether the full expression of antibody activity required such a long incubation time.
Undiluted, non-inactivated human sera from two immune donors were mixed with equal volumes of mouse brain-propagated virus containing lo 5 LDs~/o.o 3 ml and incubated at 37 °C in a thermostat-controlled water bath. As a control for antibody-independent loss of infectivity a heat-inactivated serum from a non-immune donor was run in parallel. At intervals, samples were transferred to an ice bath and titrated immediately in mice. (For titrating the control mixtures ten mice were used for each tenfold dilution step.) The results of one such experiment are presented in Table 2 ; a repeat experiment with sera from two other immune donors gave essentially the same results. These data show that neutralization was maximal after 90 rain at 37 °C.
The NF test and its application
A volume of o.i ml of undiluted native serum is measured into a narrow glass tube. Virus from brains of infected newborn mice is diluted to contain IO 4 LDs0/o'o3 ml and o.I ml is added to the serum. The tube is tightly sealed with a rubber stopper, well shaken and incubated for 9o rain at 37 °C in a water bath. The tube is then transferred to an ice bath and 1.8 ml of pre-cooled diluent is added (resulting in a tenfold dilution). Four additional tenfold dilutions are made and the titration in mice is performed as described under Methods. To allow calculation of the NF, a control consisting of virus mixed with inactivated calf serum is carried through the same procedure in parallel. Since the controls serve as comparison for a number of human sera, it is advisable to set them up in duplicate.
Since non-immune native human sera inhibit the infectivity of LCM virus somewhat, the borderline between specific and non-specific effects is of great practical interest. From the experience so far, it seems safe to say that an NF of log10 z.o or higher indicates past infection with the LCM virus, while an NF of I.O or less may be judged as negative. Values falling between I.O and 2-o are inconclusive.
Employing this method, 4o ceded sera were titrated. Of 19 which were correctly determined as having come from immune donors 18 had NF values above 2"7; one had an NF of 2. 3. One serum with an NF of 1.7 was from a laboratory worker who had contracted a serologically confirmed LCM disease 26 months previously. According to the rule of discrimination proposed, this result was considered uncertain and the test was repeated; this time the NF was 1.8. The remaining 2o sera had been correctly scored as negative. 
Determination of human antibody neutralizing LCM

DISCUSSION
Measuring LCM virus-neutralizing antibody by determining the neutralization index in mice requires more serum than is often available. Previous attempts to save serum by adopting the constant virus-variable serum arrangement have failed because of the unusual steepness of the dose-response curve relating dose of virus to the serum titre . The alternative, namely letting the antibody act on a single dose of virus and then titrating for residual infectivity, did not initially appear to be a promising approach as it was assumed that LCM virusneutralizing human antibody was of poor quality and would therefore rapidly dissociate from the virion upon dilution of the mixture. However, when the actual experiments were performed, no evidence for reactivation of infectivity was obtained, even with an interval of as long as 2 h between dilution of the mixture and its inoculation into mice.
Having found that an assay based on titrating residual virus was feasible, optimal conditions were determined. Of three additional hosts employed to propagate the virus, none was found to be superior to the mouse brain. Because of the great lability of this virus, the time of incubation had to be kept to a minimum; 9o min were found to be sufficient for maximal neutralization. Varying the dose of virus did not markedly influence the neutralization factor. This finding was not unexpected for reasons which have been extensively_discussed by Fazekas de St. Groth 0962). The decision to employ Io 4 LDs0/o.o3 ml (before addition of the serum) was based solely on considerations of practicability. Any dose of virus would do, provided it was high enough to allow its reduction by antibody to be measured. It is unlikely that the upper limit (where the concentration of free antibody would be significantly reduced) would be reached as long as unconcentrated virus is used in the assay.
To remove nonspecific inbibitors of virus infectivity, sera are usually heated before they are employed in a neutralization test. When testing for LCM virus-neutralizing antibody in human sera by means of a mouse assay, we are facing a dilemma; most human sera contain a substance which nonspecificially reduces the infectivity of the LCM virus (LehmannGrube et al. I96o; Scheid et al. I96o; Ackermann et al. I962 , and data presented here). In the case of L cell-grown virus the inhibitory factor in human serum was shown to be a complement-dependent antibody (Welsh, 1977) . Since the nonspecific inhibitor of LCM virus infectivity in human sera was always removed by raising the temperature, heating of the sera might be considered a remedy. Unfortunately, the activity of specific antibody also suffers by this treatment. The extent to which the neutralizing capacity of immune sera was reduced by heat treatment varied greatly, as shown also by the large variance of the mean reduction. Certain sera were not affected at all, while others lost so much of their activity that the NF could not be determined with confidence. For this reason it was decided not to inactivate the sera, even though this left the assay with a background of some nonspecific inhibition.
The Heinrich Pette-Institut is financially supported by Freie und Hansestadt Hamburg and Bundesministerium ftir Jugend, Familie und Gesundheit, Bonn. This work was carried out with the help of a grant from the Bundesministerium ftir Jugend, Familie und Gesundheit.
